This study aims to integrate and analyze the efficacy of IL-17 inhibitors on psoriasis from randomized controlled trials (RCTs) obtained by systematic retrieval and strict screening to explore the differential efficacy between Asian and Caucasian patients. Here, IL17A is linked to psoriasis.